Company Overview

unlife

Unilife is a U.S. based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for our products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. All of our syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. We are ISO 13485 certified and have FDA-registered medical device manufacturing facilities in Pennsylvania.

 

Our main product is the UnifillTM ready-to-fill syringe, which is designed to be supplied to pharmaceutical manufacturers in a form that is ready for filling with their injectable drugs and vaccines. We have a strategic partnership with sanofi-aventis, who has the exclusive right to negotiate for the purchase of the Unifill syringe and is funding our industrialization program. In addition, we have retained the right to negotiate with other pharmaceutical companies seeking to utilize the Unifill syringe with drugs and vaccines marketed in therapeutic areas outside of those secured exclusively by sanofi-aventis.

Multimedia

News & Events

Seeking Alpha: Unilife: Is 2013 The Tipping Point For This Pharma Stock?

By Fusion Research The next wave of technological advancement in biotechnology and the pharma industry is about bringing convenience and ease to the administration of drugs. The growth in the injectable market and increasing awareness of self-administration are driving pharma companies to come up with new and innovative produc

Motley Fool: The Medical Device Industry Offers Opportunities

By Johan Seijkens The global medical devices market reached $331 billion in 2012 according to Kalorama Information, just 3% higher than 2011. In the U.S. Medicare, Medicaid as well as state governments implemented anemic spending increases to hospitals, the key buyers of medical device products. While many of the big-tim

Unilife to Present at the Jefferies 2013 Global Healthcare Conference in New Yor

YORK, Pa., May 31, 2013 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its CEO, Alan Shortall will be presenting at the Jefferies 2013 Global Healthcare Conference in New York City at 12:30 p.m. EDT on Tuesday, June 4, 2013. The conference presentation will be broadc

UNIS Analysts Issuing Bullish Reports

Jefferies titles report “Aces in Hand: Commercial Deal Flow Appears Imminent” Jefferies analyst Raj Denhoy highlights Unilife’s “bigger stories are the EZMix and Unifill deals which are forecasted to drive meaningful revenue come F14. They reiterated their Buy Rating & $3.50 target “as the story transitions into

Follow Us
Email Alerts
  • Name:

    Email:

  • Twitter Feed